Denodo’s 2020 User Conference DataFest Draws a Record 1,800 Global Attendees Exploring Hybrid/Multi-Cloud, Cloud Integration, Data Fabric, Data Science & AI/ML
17.12.2020 11:00:00 EET | Business Wire | Press release
Denodo, the leader in data virtualization, today announced a record attendance of nearly 1,800 at its annual user conference, DataFest 2020 which was held across the NA, EMEA, and APAC regions. This year’s virtual DataFest events hosted some of the most well recognized data luminaries and subject matter experts, who immersed themselves in topics such as hybrid/multi-cloud strategies, cloud data integration, data science and AI/ML, among others. Attendees made up of Denodo customers, partners, and analysts chose the winners of Denodo’s annual Data Innovation Awards at each event, to recognize some of the exemplary use cases of logical data fabric created with data virtualization technology as the foundation.
All of the session presentations are now available for on-demand viewing, here.
“Our heartiest congratulations go out to all the winners and finalists of our Data Innovation Awards,” said Ravi Shankar, senior vice president and chief marketing officer at Denodo. “Recognizing these customers is the least we can do, as these organizations and individuals set the standard for the future of data management and exemplify some of the best use cases of logical data fabric. As we push the envelope with continuous product innovations, our customers showcased how those advancements can be put to work for even more impressive and valuable use cases.”
Like past events, this year included an esteemed panel of subject matter experts, who distilled through a slew of customer use cases to choose the finalists for each Data Innovation Award. All Denodo customers were considered for the Data Innovation Award with the winners acknowledged for demonstrating best practices, business impact, and novel implementations. The selection process highlights the many innovative uses of data virtualization at actual customer sites and provided attendees with metrics to validate its importance.
“I am absolutely thrilled to receive this year’s Data Innovation Award for the EMEA region,” said Olav Lognvik, Solution Architect at DNB. “Denodo has been the central piece in our cutting-edge data platform that supports data science use cases such as the one for mobile banking. We are glad to be able to share our success story with hundreds of data virtualization enthusiasts and as we broaden our use cases of the Denodo Platform, we hope to share more success stories in the future.”
Winners and finalists of the Denodo Data Innovation Awards 2020 include:
North America – Winner Lauren Cordova from Panasonic, for its connected car IoT/Edge and cloud analytics use case; finalist Ryan Thompson from Prologis, for their logical data lake use case.
EMEA – Winner Olav Lognvik and Christian Dancke Tuen from DNB, for its data science for mobile banking use case; finalist Tekin Mentes from LeasePlan, for their global data hub for fleet management use case.
APAC – Winner Joshua Fletcher from BHP, for its multi-cloud data fabric for global resource management use case; finalist Johan De Coning from Silver Chain, for their Healthcare with hololens and incident management system use case.
Please tweet: News: #datavirtualization leader Denodo announces the winners of its 3rd annual Data Innovation Awards during #DenodoDataFest 2020. Audience vote @Panasonic, @BHP and @DNB for the most innovative use cases.
About Denodo
Denodo is the leader in data virtualization providing agile, high performance data integration, data abstraction, and real-time data services across the broadest range of enterprise, cloud, big data, and unstructured data sources at half the cost of traditional approaches. Denodo’s customers across every major industry have gained significant business agility and ROI by enabling faster and easier access to unified business information for agile BI, big data analytics, Web, cloud integration, single-view applications, and enterprise data services. Denodo is well-funded, profitable, and privately held. For more information, visit http://www.denodo.com or call +1 877 556 2531 / +44 (0) 20 7869 8053.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005044/en/
Contact information
Chris McCoin or Richard Smith
McCoin & Smith Communications Inc.
508-429-5988 (Chris) or 978-433-3304 (Rick)
chris@mccoinsmith.com or rick@mccoinsmith.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Abu Dhabi to Imola: A2RL Expands Internationally with Historic Autonomous Racing Debut at Iconic Italian Track29.6.2026 13:12:00 EEST | Press release
The Abu Dhabi Autonomous Racing League, A2RL, will make its international racing debut on 5 September 2026 in Imola, Italy, bringing up to 5 fully autonomous racecars based on the Dallara Super Formula SF23 to one of the world’s most iconic and demanding racing circuits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629726789/en/ From Abu Dhabi to Imola: A2RL Expands Internationally with Historic Autonomous Racing Debut at Iconic Italian Track (Photo: AETOSWire) Organized by ASPIRE, the grand challenges arm of Abu Dhabi’s Advanced Technology Research Council, A2RL has quickly evolved from a bold public testbed for AI under extreme race conditions into a competitive racing series. The upcoming Imola race marks a major step in its global expansion, following two breakthrough seasons at Yas Marina Circuit in Abu Dhabi and opening the championship’s first international chapter before it returns to the UAE capital for the 202
Philip Morris International and Maestro Andrea Bocelli Present “Believe. Further”29.6.2026 13:00:00 EEST | Press release
Philip Morris International (PMI) (NYSE: PM) and Maestro Andrea Bocelli today presented “Believe. Further”, a multi-year platform designed to engage audiences in a broader conversation on progress and positive change. The launch took place at the Torre dell’Arsenale in Venice, where heritage and forward movement meet, a fitting setting for two voices on a similar path. What do you do when the world has already decided what you are? “Believe. Further” begins from that question. It is built around a shared belief in progress and a shared conviction in transformation. At a time when science and technology allow better choices, it brings together two voices that, independently and in parallel, are undergoing a change in motion, and invites the beginning of a different conversation with society at large. Maestro Bocelli’s journey has been defined by belief. From the beginnings of his career to the world’s most prestigious stages, he has followed a path shaped by conviction and the courage t
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 11:15:00 EEST | Press release
Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easier to access, navigate and manage. This will ultimately give pet parents better guidance, greater confidence and more control at every point in
Coolbrook Secures Business Finland Funding to Accelerate Electrification for the Global Steel Industry29.6.2026 11:00:00 EEST | Press release
Coolbrook, a transformational technology company dedicated to decarbonising heavy industry and industrial processes, has been awarded research and development funding by Business Finland to accelerate the decarbonisation of steel production. The grant supports Coolbrook’s participation in the FutSteel project, a core component of the Sustainable World through Steels ecosystem led by SSAB. Within the broader FutSteel project, Coolbrook’s project scope amounts to €5 million, of which €2.5 million is covered by grant funding awarded to Coolbrook. The funding will enable Coolbrook to further accelerate and develop its next-generation RotoDynamic Heater™ (RDH™) technology, specifically tailored for high-temperature steel industry applications. The project focuses on integrating RDH™ technology into critical stages of the steel production chain, including blast furnace processes, electrified reheating, hot-stove air pre-heating, hybrid-heating concepts, decarbonised Direct Reduced Iron (DRI)
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 10:19:00 EEST | Press release
Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patients with unmet needs.” Pembrolizumab is a humanized monoclonal antibody that acts as an immune checkpoint inhibitor by targeting and blocking the programmed cell death protein 1 (PD-1) receptor on T cells. It is used to treat vari
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
